Neptune Wellness Solutions Inc 's ability to collect accounts receivable sequentially worsen to 7.81, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Neptune Wellness Solutions Inc 's Accounts Receivable average collection period in the Dec 31 2023 quarter, has increased to 47 days, from 36 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 67 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 527 to 747.

What is Receivable Turnover Ratio?
What is Neptune Wellness Solutions Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEPT Receivables Turnover Ratio	(Dec 31 2023) III. Quarter	(Sep 30 2023) II. Quarter	(Jun 30 2023) I. Quarter	(Mar 31 2023) IV. Quarter	(Dec 31 2022) III. Quarter
Y / Y Receivable Change	-	-	-	-43.74 %	-
Y / Y Revenue Change	-37.75 %	-27.09 %	-34.69 %	5.34 %	-16.76 %
Receivable Turnover Ratio (TTM)	7.81	10.24	13.72	15.37	8.55
NEPT's Total Ranking	# 747	# 527	# 1004	# 1014	# 768
Accounts Receivable average collection period days	47	36	27	24	43
Seq. Receivable Change	-12.96 %	-	-	-	-
Seq. Revenue Change	-13.05 %	-17.76 %	-12.51 %	-0.5 %	1.85 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 32
Healthcare Sector	# 68
Overall Market	# 747

Receivable Turnover Ratio Statistics
High	Average	Low
54.11	23.3	2.7
(Sep 30 2022)		(Mar 31 2019)

NEPT Company Profile • Back to NEPT Efficiency Comparisons • Compare NEPT Receivables Turnover Ratio to its Competitors

Financial Statements
Neptune Wellness Solutions Inc 's Accounts Receivable	$ 3 Millions	Visit NEPT's Balance sheet
Neptune Wellness Solutions Inc 's Sales TTM	$ 39 Millions	Visit NEPT's Income Statement
Sources of NEPT's Revenues		Visit NEPT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NEPT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NEPT's Growth Rates	NEPT's Roa	NEPT's Inventory Turnover Ratio	NEPT's Dividend Comparisons
NEPT's Profitability Ratios	NEPT's Roi	NEPT's Asset Turnover Ratio	NEPT's Dividend Growth
NEPT's Valuation Ratios	NEPT's Roe	NEPT's Financial Strength Ratios	NEPT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2023	Receivable at quarter ending Dec 31 2023
Electrocore Inc	34.66	$ 15.226 Millions	$ 0.439 Millions
Sonida Senior Living Inc	34.44	$ 255.322 Millions	$ 7.413 Millions
Vireo Growth Inc.	34.09	$ 88.133 Millions	$ 2.586 Millions
Prothena Corporation Public Limited Company	33.71	$ 91.370 Millions	$ 2.710 Millions
Adaptimmune Therapeutics Plc	29.72	$ 60.281 Millions	$ 2.029 Millions
Invo Fertility Inc	27.97	$ 3.021 Millions	$ 0.108 Millions
Onemednet Corporation	27.36	$ 1.040 Millions	$ 0.038 Millions
Aesthetic Medical International Holdings Group Limited	26.71	$ 100.824 Millions	$ 3.775 Millions
Hutchmed china Limited	26.54	$ 837.999 Millions	$ 31.569 Millions
National Vision Holdings Inc	26.38	$ 2,126.468 Millions	$ 80.611 Millions
Inmed Pharmaceuticals Inc	25.61	$ 5.487 Millions	$ 0.214 Millions
Orchestra Biomed Holdings Inc	25.56	$ 2.760 Millions	$ 0.108 Millions
Cv Sciences Inc	25.51	$ 15.085 Millions	$ 0.591 Millions
Evotec Se	25.30	$ 875.197 Millions	$ 34.597 Millions
Clearside Biomedical Inc	25.18	$ 8.226 Millions	$ 0.327 Millions
Cano Health Inc	24.48	$ 3,137.757 Millions	$ 128.172 Millions
Qiagen N v	24.37	$ 1,900.688 Millions	$ 77.988 Millions
Plus Therapeutics Inc	24.29	$ 4.913 Millions	$ 0.202 Millions
Innovage Holding Corp	22.51	$ 720.796 Millions	$ 32.027 Millions
Lineage Cell Therapeutics Inc	22.09	$ 8.945 Millions	$ 0.405 Millions
Agenus Inc	21.11	$ 156.314 Millions	$ 7.406 Millions
Kymera Therapeutics Inc	20.96	$ 78.592 Millions	$ 3.750 Millions
Vystar Corporation	20.75	$ 0.526 Millions	$ 0.025 Millions
Editas Medicine Inc	20.64	$ 78.123 Millions	$ 3.784 Millions
Cue Health Inc	20.01	$ 70.936 Millions	$ 3.545 Millions
Quantum Biopharma Ltd	19.91	$ 4.556 Millions	$ 0.229 Millions
Gyre Therapeutics Inc	19.70	$ 113.450 Millions	$ 5.760 Millions
Jrsis Health Care Corp	19.27	$ 3.939 Millions	$ 0.204 Millions
Kiniksa Pharmaceuticals International Plc	19.17	$ 270.259 Millions	$ 14.095 Millions
Rosecliff Acquisition Corp I	19.08	$ 18.056 Millions	$ 0.946 Millions

Date modified: 2026-08-31T07:36:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.